Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
ABOUT THIS PAGE
36
PharmaCompass offers a list of Sodium Glycerophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier.
PharmaCompass also assists you with knowing the Sodium Glycerophosphate API Price utilized in the formulation of products. Sodium Glycerophosphate API Price is not always fixed or binding as the Sodium Glycerophosphate Price is obtained through a variety of data sources. The Sodium Glycerophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt, including repackagers and relabelers. The FDA regulates 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt supplier is an individual or a company that provides 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt active pharmaceutical ingredient (API) or 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt finished formulations upon request. The 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers may include 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt active pharmaceutical ingredient (API) in detail. Different forms of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt DMFs exist exist since differing nations have different regulations, such as 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt USDMF includes data on 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers with USDMF on PharmaCompass.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt Certificate of Suitability (COS). The purpose of a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt to their clients by showing that a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP has been issued for it. The manufacturer submits a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP holder for the record. Additionally, the data presented in the 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt DMF.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers with CEP (COS) on PharmaCompass.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt written confirmation (1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt WC) is an official document issued by a regulatory agency to a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt manufacturer, verifying that the manufacturing facility of a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt APIs or 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt finished pharmaceutical products to another nation, regulatory agencies frequently require a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt WC (written confirmation) as part of the regulatory process.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt suppliers with NDC on PharmaCompass.
1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt GMP manufacturer or 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt GMP API supplier for your needs.
A 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CoA (Certificate of Analysis) is a formal document that attests to 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt's compliance with 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt specifications and serves as a tool for batch-level quality control.
1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt EP), 1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,2,3-Propentriol, 1-(dihydrogen phosphate), sodium salt USP).
